The global analgesics market was worth US$ 44.3 Billion in 2018. Pain currently represents a major global health challenge. Worldwide, it has been estimated that 1 out of every 5 adults suffers from pain and that another 1 in in every 10 adults are diagnosed with chronic pain each year. Analgesics (also known as painkillers or pain relievers) are drugs that are taken to relieve pain. They may be taken to relieve pain that arises from a wide range of conditions, such as appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc. The two major categories of analgesics that are used to treat pain include Opioids and NSAIDs. Majority of the analgesics are taken orally. They may, however, also be taken through other delivery routes such as parenteral, topical, transdermal, rectal, etc.
The global analgesics market is expected to exhibit moderate growth over the next five years. A major factor catalyzing this demand is the strong growth in the geriatric population. In 2017, between 950 Million-1000 Million people were over the age of 60. We expect these numbers to reach 2100 Million by 2050 accounting for 21% of the total global population. The rising older population is expected to increase the incidence of pain arising from a number of chronic and lifestyle diseases. The market for analgesics is also expected to be catalyzed by a strong drug pipeline and high unmet needs. We expect a number of new drugs to be launched in the coming years. Other major factors catalyzing the analgesics market include changing lifestyles, rising prevalence of obesity and overweight, rising prevalence of chronic diseases, etc. Looking forward, the global analgesics market is expected to reach a revenue of US$ 56.8 Billion by 2024, exhibiting a CAGR of around 4% during 2019-2024.
Market Summary:
Based on the drug type, the market has been segmented into prescription analgesics and OTC analgesics. Prescription analgesics currently dominate the market, holding the largest share.
Based on the drug class, the market has been segmented into opioids, NSAIDs and others. Opioids currently represents the biggest segment.
Based on the route of administration, the market has been segmented into oral, parenteral, topical, transdermal and rectal. Currently, oral dominates the market, holding the largest share.
Based on the pain type, the market has been segmented into musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine, obstetrical pain, fibromyalgia, pain due to burns, dental/facial pain, paediatric pain and others. Musculoskeletal pain currently represents the biggest segment.
Based on the application, the market has been segmented into internal analgesics and external analgesics. Internal analgesics currently represent the biggest segment.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America currently represents the biggest market.
The competitive landscape of the market has also been examined with some of the key players being Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, etc.
Key Questions Answered in This Report:
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Properties 4.3 Key Industry Trends 5. Global Analgesics Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Type 5.4 Market Breakup by Drug Class 5.5 Market Breakup by ROA 5.6 Market Breakup by Pain Type 5.7 Market Breakup by Application 5.8 Market Breakup by Region 5.9 Market Forecast 6. Market Breakup by Type 6.1 Prescription Analgesics 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 OTC Analgesics 6.2.1 Market Trends 6.2.2 Market Forecast 7. Market Breakup by Drug Class 7.1 Opioids 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 NSAID 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Others 7.3.1 Market Trends 7.3.2 Market Forecast 8. Market Breakup by ROA 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Parenteral 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Topical 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Transdermal 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Rectal 8.5.1 Market Trends 8.5.2 Market Forecast 9. Market Breakup by Pain Type 9.1 Musculoskeletal Pain 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Surgical and Trauma Pain 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Cancer Pain 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Neuropathic Pain 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Migraine 9.5.1 Market Trends 9.5.2 Market Forecast 9.6 Obstetrical Pain 9.6.1 Market Trends 9.6.2 Market Forecast 9.7 Fibromyalgia 9.7.1 Market Trends 9.7.2 Market Forecast 9.8 Pain due to Burns 9.8.1 Market Trends 9.8.2 Market Forecast 9.9 Dental/Facial Pain 9.9.1 Market Trends 9.9.2 Market Forecast 9.10 Pediatric Pain 9.10.1 Market Trends 9.10.2 Market Forecast 9.11 Others 9.11.1 Market Trends 9.11.2 Market Forecast 10. Market Breakup by Application 10.1 Internal Analgesics 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 External Analgesics 10.2.1 Market Trends 10.2.2 Market Forecast 11. Market Breakup by Region 11.1 North America 11.1.1 Market Trends 11.1.2 Market Forecast 11.2 Europe 11.2.1 Market Trends 11.2.2 Market Forecast 11.3 Asia Pacific 11.3.1 Market Trends 11.3.2 Market Forecast 11.4 Middle East and Africa 11.4.1 Market Trends 11.4.2 Market Forecast 11.5 Latin America 11.5.1 Market Trends 11.5.2 Market Forecast 12. Global Analgesics Industry: SWOT Analysis 12.1 Overview 12.2 Strengths 12.3 Weaknesses 12.4 Opportunities 12.5 Threats 13. Global Analgesics Industry: Value Chain Analysis 13.1 Overview 13.2 Research and Development 13.3 Raw Material Procurement 13.4 Manufacturing 13.5 Marketing 13.6 Distribution 13.7 End-Use 14. Global Analgesics Industry: Porters Five Forces Analysis 14.1 Overview 14.2 Bargaining Power of Buyers 14.3 Bargaining Power of Suppliers 14.4 Degree of Competition 14.5 Threat of New Entrants 14.6 Threat of Substitutes 15. Global Analgesics Industry: Price Analysis 15.1 Price Indicators 15.2 Price Structure 15.3 Margin Analysis 16. Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players 16.3.1 Bayer AG 16.3.2 Novartis AG 16.3.3 GlaxoSmithKline PLC 16.3.4 Pfizer Inc. 16.3.5 Johnson & Johnson 16.3.6 Reckitt Benckiser (RB) 16.3.7 Endo Pharmaceuticals 16.3.8 Bristol-Myers Squibb 16.3.9 Eli Lilly and Company 16.3.10 Sanofi |
Market Breakup by Type
Market Breakup by Drug Class
Market Breakup by ROA
Market Breakup by Pain Type
Market Breakup by Application
Market Breakup by Region